ArticleScientific reports2017

Incidence and predictors of HBV relapse after cessation of nucleoside analogues in HBeAg-negative patients with HBsAg ≤ 200 IU/mL.

Chih-Chien Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.